Ondansetron Injection

Related by string. * ondansetron : Ondansetron Orally Disintegrating Tablets . ondansetron Oral Spray . ondansetron RapidFilm . Ondansetron Hydrochloride . Ondansetron RapidFilm / Injections . INJECTION . INJECTIONS . injections : lethal injection procedures . lethal injection protocol . lethal injection executions . lethal injection method * Ondansetron Injection USP *

Related by context. Frequent words. (Click for all words.) 71 gets USFDA nod 68 topical non steroidal 67 BioGlue R 66 Completes Patient Enrollment 66 Receives Orphan Drug Designation 66 Transcept Pharmaceuticals 65 Initiates Phase II 65 Generic Version 65 Company Nasdaq PRGO 65 FDA Accepts 65 Presents Positive 64 CPL Biologicals 64 Teva Pharma 64 Announces FDA Clearance 63 Inc Therapeutic Competitors 63 Taiho Pharmaceutical 63 NASDAQ AKRX 63 Valeant Pharma 63 Glenmark Generics 63 Announces Initiation 63 Commences Phase 62 Enrolls First 62 Paladin Labs 62 Argatroban 62 Peng Lai Jin Chuang 62 Receives FDA Clearance 62 FDA Clears 62 Completes Enrollment 62 Shareholders Approve Acquisition 62 Geekzone ® SohoSolutions 62 Completes Tender Offer 62 Files Shelf Registration Statement 62 Executes Agreement 62 Attracting Bullish Investors 62 FACTIVE R gemifloxacin 62 Akorn Strides LLC 62 Meets Primary Endpoint 62 Stavzor 62 R sorafenib tablets 61 Receives Regulatory 61 Elan Pharma 61 Release Tablets 61 CRXL 61 Fortical R 61 Crucell NV NYSE Euronext 61 NASDAQ CRXL 61 Ipca Laboratories 61 include LibiGel ® 61 cheap viagra paypal 61 Kuvan R 61 Receives CE 61 DRRX 61 Milestone Payment 61 Inhalation Aerosol 61 monobasic monohydrate USP 61 PLIVA dd 60 DOV Pharmaceutical Inc. 60 Signs License Agreement 60 Develop Novel 60 Par Pharma 60 Jumps Higher 60 IIROC Halt 60 Joins OTCQX 60 Patient Enrollment 60 Copegus R 60 Vytorin combines 60 Barrier Therapeutics Inc. 60 Nasdaq CRXL 60 Recombinant Human 60 Announces Postponement 60 Tibotec Pharmaceuticals Ltd. 60 FDA Approves 60 Omigard TM 60 KV Pharma 60 Initiates Phase 60 NYSE COV 60 Announces Shareholder Approval 59 Drug Candidate 59 Therapeutic Competitors 59 Underwritten Public 59 Rotarix R 59 Application MAA 59 Divis Labs 59 Stockholders Approve Merger 59 Q1 Loss Narrows 59 Penwest Pharmaceuticals 59 Kopran 59 Par Pharmaceuticals 59 Oral Solution 59 mg Tablets 59 BYETTA ® 59 Receives Patent 59 Increases Ownership 59 USFDA approval 59 Ceftriaxone 59 topical anti infective 59 ZEGERID Capsules 59 Elevess 59 injection USP 59 Duramed Pharmaceuticals Inc. 59 Fast Track Status

Back to home page